Similarly, chronic activation of NF-κB in hepatocytes contributes to the development of cholestatic hepatitis followed by hepatocellular carcinoma in a mouse model with genetic deficiency in multidrug resistance 2 (Mdr2) [283]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.